Bone-targeted therapies to reduce skeletal morbidity in prostate cancer

od Dorff, Tanya B, Agarwal, Neeraj
izdano v Asian J Androl (2018)

The Epothilones: New Therapeutic Agents for Castration-Resistant Prostate Cancer

od Dorff, Tanya B., Gross, Mitchell E.
Izdano 2011

Current Role of Neoadjuvant and Adjuvant Systemic Therapy for High-risk Localized Prostate Cancer

od Dorff, Tanya B., Glode, L. Michael
izdano v Curr Opin Urol (2013)

Targeted therapy in renal cancer

od Dorff, Tanya B., Goldkorn, Amir, Quinn, David I.
Izdano 2009

Clinical use of cabozantinib in the treatment of advanced kidney cancer: efficacy, safety, and patient selection

od Yu, Steven S, Quinn, David I, Dorff, Tanya B
izdano v Onco Targets Ther (2016)

Current Management Strategy for Penile Cancer and Future Directions

od Dorff, Tanya B., Ballas, Leslie K., Schuckman, Anne K.
izdano v Curr Oncol Rep (2017)

Tivozanib in the treatment of renal cell carcinoma

od Hepgur, Mehmet, Sadeghi, Sarmad, Dorff, Tanya B, Quinn, David I
Izdano 2013

Current and recent clinical trials for perioperative systemic therapy for muscle invasive bladder cancer: a systematic review

od Vashistha, Vishal, Quinn, David I, Dorff, Tanya B, Daneshmand, Siamak
izdano v BMC Cancer (2014)

Wnt/β-Catenin Signaling and Immunotherapy Resistance: Lessons for the Treatment of Urothelial Carcinoma

od Chehrazi-Raffle, Alexander, Dorff, Tanya B., Pal, Sumanta K., Lyou, Yung
izdano v Cancers (Basel) (2021)

Immunotherapy in Urothelial Cancer, Part 1: T-Cell Checkpoint Inhibition in Advanced or Metastatic Disease

od Yu, Steven S., Dorff, Tanya B., Ballas, Leslie K., Sadeghi, Sarmad, Skinner, Eila C., Quinn, David I.
izdano v Clin Adv Hematol Oncol (2017)

Immunotherapy in Urothelial Cancer, Part 2: Adjuvant, Neoadjuvant, and Adjunctive Treatment

od Yu, Steven S., Ballas, Leslie K., Skinner, Eila C., Dorff, Tanya B., Sadeghi, Sarmad, Quinn, David I.
izdano v Clin Adv Hematol Oncol (2017)

Safety and Efficacy of Docetaxel, Bevacizumab, and Everolimus for Castration-resistant Prostate Cancer (CRPC)

od Gross, Mitchell E., Dorff, Tanya B., Quinn, David I., Diaz, Patricia M., Castellanos, Olga O., Agus, David B.
izdano v Clin Genitourin Cancer (2017)

Immune Response to Sipuleucel-T in Prostate Cancer

od Thara, Eddie, Dorff, Tanya B., Averia-Suboc, Monica, Luther, Michael, Reed, Mary E., Pinski, Jacek K., Quinn, David I.
Izdano 2012

Impact of resistance training on body composition and metabolic syndrome variables during androgen deprivation therapy for prostate cancer: a pilot randomized controlled trial

od Dawson, Jacqueline K., Dorff, Tanya B., Todd Schroeder, E., Lane, Christianne J., Gross, Mitchell E., Dieli-Conwright, Christina M.
izdano v BMC Cancer (2018)

Baseline (18)F-FDG PET/CT Parameters as Imaging Biomarkers of Overall Survival in Castrate-Resistant Metastatic Prostate Cancer

od Jadvar, Hossein, Desai, Bhushan, Ji, Lingyun, Conti, Peter S., Dorff, Tanya B., Groshen, Susan G., Pinski, Jacek K., Quinn, David I.
Izdano 2013

Baseline Glomerular Filtration Rate and Cisplatin- Induced Renal Toxicity in Urothelial Cancer Patients

od Loh, Janice M., Tran, Adrienne L., Ji, Lingyun, Groshen, Susan, Daneshmand, Siamak, Schuckman, Anne, Quinn, David I., Dorff, Tanya B.
izdano v Clin Genitourin Cancer (2017)

A Phase II Trial of a Combination Herbal Supplement for Men with Biochemically Recurrent Prostate Cancer

od Dorff, Tanya B., Groshen, Susan, Tsao-Wei, Denice D., Xiong, Shigang, Gross, Mitchell E., Vogelzang, Nicholas, Quinn, David I., Pinski, Jacek K.
izdano v Prostate Cancer Prostatic Dis (2014)

Phase 2 Trial of Monoamine Oxidase Inhibitor Phenelzine in Biochemical Recurrent Prostate Cancer

od Gross, Mitchell E., Agus, David B., Dorff, Tanya B., Pinski, Jacek K., Quinn, David I., Castellanos, Olga, Gilmore, Patrick, Shih, Jean C.
izdano v Prostate Cancer Prostatic Dis (2020)

Prospective Evaluation of (18)F-NaF and (18)F-FDG PET/CT in Detection of Occult Metastatic Disease in Biochemical Recurrence of Prostate Cancer

od Jadvar, Hossein, Desai, Bhushan, Ji, Lingyun, Conti, Peter S., Dorff, Tanya B., Groshen, Susan G., Gross, Mitchell E., Pinski, Jacek K., Quinn, David I.
Izdano 2012

Randomized Phase II Trial of Abiraterone Alone or With Dasatinib in Men With Metastatic Castration-resistant Prostate Cancer (mCRPC)

od Dorff, Tanya B., Quinn, David I., Pinski, Jacek K., Goldkorn, Amir, Sadeghi, Sarmad, Tsao-Wei, Denice, Groshen, Susan, Kuhn, Peter, Gross, Mitchell E.
izdano v Clin Genitourin Cancer (2019)